Heritage Pharmacy Case Law
Summary of Violations
In case number 4904 the following violations were accused to ESTHER KIM and ALLAN PIWONKA working for INNOVATIVE COMPOUNDING SOLUTIONS, DBA HERITAGE COMPOUNDING PHARMAY from the BOARD OF PHARMACY DEPARTMENT OF CONSUMER AFFAIR STATE OF CALIFORNIA:
In this legal document there are 12 causes for discipline that were discovered by the board investigative processes that took place over the course of several months. The first problem deals with Kim's husband having access to the pharmacy and all the dangerous drugs associated with the storage of these substances. Kim is accused in the second cause for discipline for furnishing dangerous drugs without a prescription.
The third cause for discipline is related to Kim's practice of varying too much from the prescription and issuing unsafe doses of drugs for their customers. This problem originates from the fourth cause for discipline which relates to Kim's writing, filing, compounding, issuing and dispensing false prescriptions. The fifth cause for discipline is also related to the aforementioned issues as well as this cause for discipline was issued for refilling controlled substances more than six months after a prescription was written.
Kim is also accused of submitting false information to CURES regarding the previous behaviors that reflect this problem. The seventh cause for discipline is a more general and less specific offense that accuses Kim of committing an act involving dishonesty, fraud and deceit. To complicate these matters, the board accused Kim in the eighth cause for discipline for making a document that falsely represents the existence of a fact.
Kim and Heritage are also being investigated for a ninth cause for discipline which involves Kim's engaging in conduct that subverts or attempts to subvert a board investigation. The tenth cause for discipline the board has brought to the accused deals...
Pharmacy Career Info. As if the pharmaceutical companies and the pharmacists at drug stores need something more to worry about, the latest issue is drug counterfeiting. While this issue in the United States is still rare, the number of investigations are on the rise. According to the Food and Drug Administration (FDA), the number of counterfeit drug investigations has risen from an average of five per year in the 1990s to
In summary, we recommend that the IESBA reconsiders the proposals in the Exposure Draft and provides more guidance on safeguards applicable to sole practitioners and small accounting firms to ensure that the benefits of the changes outweigh the costs to SMEs. Under a principle-based approach, there should be safeguards and practical relief for all practitioners rather than rules-based outright prohibitions. The rewrite of this Independence component of the Code
How serious was this e-mail security breach? Why did the Kaiser Permanente leadership react so quickly to mitigate the possible damage done by the breach?The e-mail security breach by the KP online Pharmacy was grave because it violated various HIPPA and State laws that protect patients from health information disclosure without prior consent. Moreover, such a breach of confidential and private information could cause harm and affect the patients' dignity.
Robert Ray Courtney Case Background In 1998, One of Robert Courtney's sales employees, Eli Lilly, noticed inconsistencies between the quantity of the cancer drug Gemzar that Courtney shipped in and the amount he sold. Lilly upon investigation of the issue was unsuccessful in unearthing any evidence of illegality and concluded the issue without further action. Two years later, Eli mentioned the issue to a medical practitioner who worked in the same building
3). How exactly did he get caught? After learning that it was possible that Courtney was diluting medications, the FBI and the Food and Drug Administration (FDA) arranged a sting. In the sting, one of Courtney's customers (Hunter) ordered six prescriptions from Research Medical Tower Pharmacy (Courtney's company); the results of the tests on those drugs showed that "each had been diluted to between 17 and 39% of the
Drug Development (From Nature to the Market) The process of drug development is a complex one. The pharmaceutical industry is required to adhere to strict governmental regulations, set out by the Food and Drug Administration (FDA), which involve numerous phases of testing and clinical trials, close monitoring of the drug's effects on users, its stability, dosage forms (the preparation), and so on. This paper will describe the drug development process,
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now